FREDERICK W DRISCOLL
CIK 1129890 · Chief Financial Officer · last filed 2025-11-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$220.9K
Companies
11
Total Filings
66
Lifetime Open-Market Net
-$1.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LITS | Director | — | $0.74 | — | $0 | 1 | 2025-11-18 |
| Lite Strategy, Inc. (MEIP) Delisted | Director | 1,875 | $3.20 | $6.0K | -$625 | 10 | 2025-07-17 |
| CLRB | Director | 19,417 | $2.23 | $43.3K | $20.2K | 6 | 2025-02-18 |
| CUE | Director | — | $24.53 | — | $0 | 8 | 2025-01-03 |
| Renovacor, Inc. (RCOR.WS) Delisted | Chief Financial Officer | — | $0.07 | — | $0 | 1 | 2022-03-28 |
| FLXN | Chief Financial Officer | 0 | $25.05 | $0 | -$689.0K | 14 | 2021-11-19 |
| ImmunityBio, Inc. (NK) Delisted | Director | 124,535 | — | — | -$668.1K | 5 | 2020-08-13 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Director | — | $0.12 | — | $0 | 4 | 2020-06-25 |
| Oncotelic Therapeutics, Inc. (OXGN) Delisted | Director | — | — | — | $0 | 4 | 2016-06-03 |
| NVAX | VP, CFO & Treasurer | 20,000 | $8.88 | $177.6K | $23.6K | 7 | 2013-03-06 |
| GENELABS TECHNOLOGIES INC /CA (GNLB) Delisted | CEO | 0 | — | — | $10.0K | 6 | 2009-01-07 |
Recent Filings · Page 3 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-13 | ImmunityBio, Inc. (NK) Delisted | Sell (S) | −65,300 | -$668.1K | EDGAR |
| 2020-07-07 | Lite Strategy, Inc. (MEIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | ImmunityBio, Inc. (NK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | CUE | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | Lite Strategy, Inc. (MEIP) Delisted | Buy (P) | +62,500 | $100.0K | EDGAR |
| 2019-07-03 | Lite Strategy, Inc. (MEIP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-14 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | ImmunityBio, Inc. (NK) Delisted | Grant (A) | +92,592 | $0 | EDGAR |
| 2019-01-03 | CUE | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.